- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT03337867
Theta-Burst-Stimulation in Recurrent Stroke Recovery
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
To date, the majority of neuromodulation approaches aiming at improving motor recovery after stroke are limited to patients with first-ever ischemic stroke. Therefore, rehabilitation of recurrent stroke mainly includes physiotherapy and occupational therapy. Yet, particular these patients retain movement impairment relevant for activities of daily living.
By using repetitive transcranial magnetic stimulation (rTMS), it is possible to promote recovery of connectivity between brain regions, particularly after stroke and thereby improve motor performance. Previous data indicate that intermittent theta-burst stimulation (iTBS), a protocol of neuromodulation, enhances the effects of subsequent motor training in early rehabilitation after stroke.
The current study aims at investigating whether daily repetitive transcranial magnetic stimulation over 8 days combined with subsequent physiotherapy leads to better motor recovery in recurrent stroke, compared to control condition, physiotherapy after sham stimulation. Motor function, degree of disability and quality of life are examined in order to evaluate the effects of iTBS in the rehabilitation of recurrent stroke patients in the first weeks and after three months.
Tipo di studio
Iscrizione (Anticipato)
Fase
- Fase 2
Contatti e Sedi
Luoghi di studio
-
-
-
Cologne, Germania, 50937
- Christian Grefkles
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- written consent
- age: 40-90 years
- recurrent stroke
- hemiparesis with impaired hand motor function
Exclusion Criteria:
- Subjects who are legally detained in an official institute (§20 MPG)
- Electronic implants or ferromagnetic Implants located in the head, neck or thorax (e.g. clips, intracranial shunt, artificial heart valve, pacemaker)
- Medication pump (e.g. insulin pump)
- Metal splinters in eye or head
- Pregnancy / breastfeeding
- Severe Neurodegenerative disease
- Severe Neuroinflammatory disease
- History of seizures / epilepsy
- Physical addiction to alcohol, medication, or drugs (excluded: nicotine)
- Insufficient compliance
- Present or past malignant tumor involving the central nervous system
- Severe Psychiatric disease
- Frequent medication with benzodiazepines, high-potency antipsychotics or tricyclic antidepressants before hospitalization or long-term during hospitalization
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Scienza basilare
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Triplicare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
---|---|
Comparatore attivo: Real-iTBS
|
Intermittent theta-burst-stimulation (iTBS) protocol
Sham stimulation
|
Comparatore fittizio: Sham-iTBS
|
Intermittent theta-burst-stimulation (iTBS) protocol
Sham stimulation
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
Relative grip force
Lasso di tempo: 3 months after enrollment
|
grip force as measured with vigorimeter
|
3 months after enrollment
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
Relative grip force
Lasso di tempo: After 8 days of intervention, and 3 months of enrollment
|
Grip force as measured with vigorimeter
|
After 8 days of intervention, and 3 months of enrollment
|
Motor function
Lasso di tempo: After 8 days of intervention, and 3 months of enrollment
|
Action Research Arm Test, ARAT
|
After 8 days of intervention, and 3 months of enrollment
|
Motor function
Lasso di tempo: After 8 days of intervention, and 3 months of enrollment
|
Fugl-Meyer Motor Scale of the upper extremity, FM The Fugl-Meyer Assessment scale is an ordinal scale that has 3 points for each item. A zero score is given for the item if the subject cannot do the task. A score of 1 is given when the task is performed partially and a score of 2 is given when the task is performed fully. Minimum score in upper limb = 0 Maximum score in upper limb = 66, Subscales are summed |
After 8 days of intervention, and 3 months of enrollment
|
Stroke severity
Lasso di tempo: After 8 days of intervention, and 3 months of enrollment
|
National Instituts of Health Stroke Scale, NIHSS The NIHSS is composed of 11 items, each of which scores a specific ability between a 0 and 4. For each item, a score of 0 typically indicates normal function in that specific ability, while a higher score is indicative of some level of impairment. The individual scores from each item are summed in order to calculate a patient's total NIHSS score. The maximum possible score is 42, with the minimum score being a 0. |
After 8 days of intervention, and 3 months of enrollment
|
Degree of disability
Lasso di tempo: After 8 days of intervention, and 3 months of enrollment
|
Modified Rankin Scale, mRS The scale runs from 0-6, running from perfect health (0) without symptoms to death (6).
|
After 8 days of intervention, and 3 months of enrollment
|
Motor cortex excitability/ Motor evoked potential
Lasso di tempo: After 8 days of intervention, and 3 months of enrollment
|
Motor evoked potential (MEP) induced by stimulation of the affected motor cortex
|
After 8 days of intervention, and 3 months of enrollment
|
Motor cortex excitability/ Resting motor threshold
Lasso di tempo: After 8 days of intervention, and 3 months of enrollment
|
Resting motor threshold as measured by stimulation of the affected motor cortex, RMT
|
After 8 days of intervention, and 3 months of enrollment
|
Motor cortex excitability/ Short-interval intracortical inhibition
Lasso di tempo: After 8 days of intervention, and 3 months of enrollment
|
Short-interval intracortical inhibition Short-interval intracortical inhibition (SICI) is a widely used paired-pulse transcranial magnetic stimulation (TMS) measure to assess inhibition in human motor cortex
|
After 8 days of intervention, and 3 months of enrollment
|
Motor cortex excitability/ Ipsilateral silent period
Lasso di tempo: After 8 days of intervention, and 3 months of enrollment
|
Ipsilateral silent period The ipsilateral silent period (iSP) is supposed to be a specific marker of transcallosal motor inhibition.
Measured by a short attenuation or interruption of ongoing voluntary electromyographic (EMG) activity in hand muscles induced by focal TMS of the ipsilateral M1.
|
After 8 days of intervention, and 3 months of enrollment
|
Quality of life
Lasso di tempo: After 8 days of intervention, and 3 months of enrollment
|
EuroQol 5D questionnaire, EQ-5D
|
After 8 days of intervention, and 3 months of enrollment
|
Activities of daily living at admission and discharge in external rehabilitation facility
Lasso di tempo: After 8 days of intervention, and 3 months of enrollment
|
Barthel-Index (BI) scores as documented by external rehabilitation facility The Barthel scale is an ordinal scale used to measure performance in activities of daily living (ADL).
A higher number is associated with a greater likelihood of being able to live at home with a degree of independence following discharge from hospital.
The scale yield a score of 0-100.
|
After 8 days of intervention, and 3 months of enrollment
|
Days of rehabilitation after intervention phase
Lasso di tempo: 3 months after enrollment
|
Days of rehabilitation after intervention phase as documented by external rehabilitation facility
|
3 months after enrollment
|
Collaboratori e investigatori
Sponsor
Investigatori
- Investigatore principale: Christian Grefkes, MD, University Hospital Cologne
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Anticipato)
Completamento dello studio (Anticipato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- U1111-1204-6783
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Magstim Super Rapid2 System
-
Bradley HospitalThrasher Research Fund; Rhode Island FoundationSconosciutoADHD con deficit di memoria di lavoroStati Uniti
-
NYU Langone HealthCompletato
-
UMC UtrechtCompletato
-
University of LiegeRitiratoEmicrania cronicaBelgio
-
Taipei Medical University WanFang HospitalCompletato
-
University of ManitobaReclutamentoAfasia Logopenica ProgressivaCanada
-
New York State Psychiatric InstituteCompletatoDisturbo di depersonalizzazioneStati Uniti
-
Ankara City Hospital BilkentCompletatoDepressione post-ictusTacchino
-
Ankara City Hospital BilkentCompletato
-
Yale UniversityAmerican Academy of Child Adolescent Psychiatry.ReclutamentoDisturbo dello spettro autisticoStati Uniti